Health Care
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 2,656.00 | 969.08 | 99.00 | 55.4 | 3.5 | +16% | 369.58 | 6.7% |
31-Dec-21 | 5,224.71 | 2,232.32 | 235.00 | 27.3 | 0.2 | +137% | 217.00 | 3.4% |
31-Dec-22 | 3,605.05 | 853.65 | 90.00 | 35.2 | n/a | -62% | n/a | 0.0% |
31-Dec-23 | 4,122.51 | 737.36 | 85.00 | 20.8 | n/a | -6% | n/a | 0.0% |
31-Dec-24 | 5,719.74 | 1,439.59 | 182.00 | 12.0 | 0.1 | +114% | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 7,624.18 | 1,855.59 | n/a | n/a | n/a | -100% | n/a | 0.0% |
31-Dec-26 | 8,925.21 | 2,383.28 | n/a | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 9,870.24 | 2,775.05 | n/a | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | 17.47 | 8.59 | 13.73 | 0.73 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | US Dollars |
Share Price | $ 0.36 |
Change Today | $ 0.02 |
% Change | 5.81 % |
52 Week High | $0.5 |
52 Week Low | $0.2 |
Volume | 5,809 |
Shares Issued | 562.65m |
Market Cap | $204.81m |
Beta | 0.05 |
RiskGrade | 224 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 0 |
Buy | 2 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 08-Jul-21 | 10-Sep-20 |
Paid | 29-Jul-21 | 02-Oct-20 |
Amount | 4.90¢ | 18.70¢ |
Time | Volume / Share Price |
13:46 | 100 @ $0.36 |
13:46 | 100 @ $0.36 |
13:46 | 100 @ $0.36 |
12:26 | 3,709 @ $0.36 |
08:00 | 27 @ $0.36 |
CFO | Ahmed El Gebeily |
CFO | Sherif El Zeiny |
You are here: research